Testing effectiveness (Phase 2)Looking for participantsNCT07460180
What this trial is testing
The PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cytoreductive Surgery and HIPEC in Ovarian Cancer
Who this might be right for
Ovarian CancerEpithelial CancerFallopian Tube Cancer
The Netherlands Cancer Institute 55